Markers of treatment response to methotrexate in rheumatoid arthritis: where do we stand?
{{output}}
Methotrexate (MTX) is the most commonly used disease-modifying antirheumatic drug (DMARD) for the treatment of rheumatoid arthritis (RA). However, despite its efficacy and affordability, additional DMARDs or biologic agents are often required in order to achie... ...
